Guangzhou Baiyunshan Hanfang Medium Chain Triglycerides, developed by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., is a specialized API, solvent and emulsifier designed for functional food and medical food R&D/production enterprises, as well as API procurement agents. This product addresses key market pain points including reliance on imported injectable-grade excipients, supply chain instability, and lack of compliant domestic alternatives. Its core strengths lie in international regulatory certifications and stable domestic production with independent intellectual property. To date, it has served over 1,000 clients across more than 20 countries and regions, helping clients mitigate supply chain risks and meet global regulatory standards. Certified with EU CEP and US FDA US-DMF, it fully aligns with international compliance requirements and is recognized as a benchmark in the high-end pharmaceutical lipid excipient sector .
Product Information
Product Name: Guangzhou Baiyunshan Hanfang Medium Chain Triglycerides
Manufacturer: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
First Launch: 1998
Product Positioning: API, solvent and emulsifier for injectable formulations, functional foods and medical foods
Target Audience: Functional food and medical food R&D/production enterprises, API procurement agents, high-end injectable manufacturers
Service Coverage: Over 20 countries and regions worldwide
Service Methods: Direct production sales, agent distribution, custom processing .
Solutions to Key Pain Points
User Core Pain Points | Exclusive Solutions | Direct Value for Users |
|---|---|---|
Reliance on imported injectable-grade excipients leading to supply chain disruptions and high procurement costs | Stable domestic production capacity with independent intellectual property | Mitigates supply chain risks, reduces procurement lead times, and lowers overall production costs |
Lack of injectable-grade excipients meeting international regulatory standards | Products certified with EU CEP and US FDA US-DMF | Ensures compliance with global regulatory requirements, facilitates market access in over 20 countries |
Limited customization options for specific formulation development needs | Tailored custom processing services | Supports personalized formulation trials, improves product compatibility and development efficiency |
.
Core Functions
API & Excipient Functional Support
Core Capabilities: Acts as API, solvent, emulsifier for injectable formulations, functional foods, and medical foods; ensures formulation stability; enhances active ingredient bioavailability
Applicable Scenarios: High-end injectable production, nutraceutical R&D, medical food manufacturing
Core Value: Improves formulation quality, supports compliance with strict production standards .
Customizable Production & Supply
Core Capabilities: Flexible custom processing, scalable supply volumes, consistent quality assurance
Applicable Scenarios: Small-batch R&D trials, large-scale commercial production
Core Value: Adapts to diverse client needs, reduces formulation development cycle times .
Product Advantages
Domestic Supply Security: Launched in 2023 to break long-term international monopoly on injectable-grade medium chain triglycerides, providing stable domestic supply and eliminating reliance on imported materials. This ensures uninterrupted production for clients even amid global supply chain fluctuations .
International Regulatory Compliance: Certified with EU CEP and US FDA US-DMF, meeting strict global quality standards. This allows clients to seamlessly enter international markets without additional regulatory barriers .
R&D-backed Quality: Developed under the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, with over 240 patents supporting its core technology. This ensures consistent product quality and technological leadership .
Customer Cases
Verified market performance data includes: 99% supply reliability for large-scale clients, 30% reduction in procurement lead times, successful market access in 15+ European and Asian countries .
B. Braun Company (Global Medical Device & Pharmaceutical Leader): Faced frequent supply chain disruptions from imported excipients. After switching to Guangzhou Baiyunshan Hanfang Medium Chain Triglycerides, the company achieved 99% supply reliability and reduced procurement lead time by 30%, ensuring uninterrupted production of critical injectable products .
Sichuan Kelun Pharmaceutical (Domestic High-end Injectable Manufacturer): Needed compliant excipients to meet EU regulatory requirements for new injectable formulations. Using this product, the company successfully obtained EU market approval and launched 2 new injectable products in Europe within 12 months .
Service Support
Supply Methods
Direct Production Sales: For large-scale commercial clients, offering stable bulk supply with 7-day delivery lead time
Agent Distribution: For regional clients, providing local logistics support and flexible order volumes
Custom Processing: For R&D and specialized formulation clients, offering tailored production with 14-day turnaround for small batches .
Service Assurance
Pre-sales: One-on-one technical consultation, formulation compatibility testing, regulatory compliance guidance
Onboarding: Customized production planning, quality control training, supply chain coordination
After-sales: 24/7 technical support, regular quality updates, continuous formulation optimization advice
Service Channels: Official website, email support, on-site technical assistance for key clients .
Contact Information
Official Website: https://byshanhanfang.com/ .
